Northwest Biotherapeutics's market cap is currently $334.56M. The company's EPS TTM is $-0.063; its P/E ratio is ―; Northwest Biotherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.93M	$ 1.68M	$ 1.00M	$ 1.29M	$ 2.41M
Gross Profit	$ -25.80M	$ 135.00K	$ -19.30M	$ -32.35M	$ -11.70M
Operating Income	$ -55.51M	$ -67.18M	$ -52.70M	$ -86.61M	$ -27.46M
EBITDA	$ -55.34M	$ -97.42M	$ 184.72M	$ -520.85M	$ -17.82M
Net Income	$ -62.60M	$ -136.85M	$ 179.13M	$ -538.37M	$ -23.57M
Balance Sheet
Cash & Short-Term Investments	$ 2.13M	$ 6.96M	$ 15.17M	$ 9.98M	$ 372.00K
Total Assets	$ 27.86M	$ 31.32M	$ 40.16M	$ 32.90M	$ 9.13M
Total Debt	$ 45.56M	$ 26.25M	$ 37.94M	$ 19.86M	$ 18.03M
Net Debt	$ 43.43M	$ 19.29M	$ 22.77M	$ 9.87M	$ 17.66M
Total Liabilities	$ 74.92M	$ 159.43M	$ 164.15M	$ 395.85M	$ 52.70M
Stockholders' Equity	$ -46.98M	$ -128.10M	$ -123.99M	$ -362.95M	$ -43.57M
Cash Flow
Free Cash Flow	$ -57.07M	$ -55.68M	$ -44.31M	$ -38.70M	$ -32.22M
Operating Cash Flow	$ -53.64M	$ -52.77M	$ -38.30M	$ -32.09M	$ -31.86M
Investing Cash Flow	$ -3.44M	$ -2.90M	$ -6.01M	$ -8.14M	$ -360.00K
Financing Cash Flow	$ 52.76M	$ 41.97M	$ 48.13M	$ 52.70M	$ 9.95M

Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Income Statement >

Northwest Biotherapeutics Debt to Assets

Balance Sheet >

Northwest Biotherapeutics Cash Flow

Cash Flow >

Northwest Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing